Pregio Pharma Private Limited, a active private limited company, was established on 30 March 2011 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24297TN2011PTC079939. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹13.00 Cr and a paid-up capital of ₹12.32 Cr.
It upholds a compliant status. Its leadership includes Muthuvelayudham Sivakumar (Managing Director), Sasikumar (Director). Past directors included Mohanrajulu Srinivasa Naidu, Deivasigamani Shanmuga Sundaram, Arumugam Saravanan. It holds ₹12.20 Cr open charges and ₹8.40 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1035 A New No 11 H- Block 24Th Street Anna Nagar West Chennai 600040, Chennai, Tamil Nadu, 600040.
U24297TN2011PTC079939
079939
30 March 2011
₹13.00 Cr
₹12.32 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Pregio Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Muthuvelayudham Sivakumar | Managing Director | 30 Mar 2011 | Current |
| Sasikumar | Director | 28 Oct 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 11 Jun 2022 | Past |
| Pramod Abcsdd | Additional Director | 04 Nov 2022 | Past |
| Pramod Abcsdd | Director | 16 Apr 2019 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Company Secretary | 06 Jan 2025 | Past |
| Pramod Abcsdd | Director | 09 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pregio Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.61% increase. The company also saw a substantial improvement in profitability, with a 21.4% increase in profit. The company's net worth moved up by a moderate rise of 7.88%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Pregio Pharma had a promoter holding of 11.13% and a public holding of 88.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹122,003,000.00
₹84,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2023 | Indian Overseas Bank | ₹0.80 M | Open |
| 28 Jul 2023 | Indian Overseas Bank | ₹12.12 Cr | Open |
| 31 Dec 2019 | The South Indian Bank Limited | ₹4.42 Cr | Satisfied |
| 30 May 2013 | Others | ₹3.98 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Pregio Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pregio Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pregio Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Indian Overseas Bank of Rs. 12.12 Cr registered on 28 Jul 2023 with Charge ID 100765547 was modified on 27 May 2025. was recorded as a recent event.
The activity Pregio Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Pregio Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
The activity A charge with Indian Overseas Bank amounted to Rs. 0.08 Cr with Charge ID 100825195 was registered on 21 Nov 2023. was completed.
The activity A charge registered on 31 Dec 2019 via Charge ID 100318226 with The South Indian Bank Limited was fully satisfied on 17 Aug 2023. was completed.
A charge with Indian Overseas Bank amounted to Rs. 12.12 Cr with Charge ID 100765547 was registered on 28 Jul 2023. was recorded as a recent event.
The CIN of Pregio Pharma Private Limited is U24297TN2011PTC079939.
Pregio Pharma Private Limited is headquartered at 1035 A New No 11 H- Block 24Th Street Anna Nagar West Chennai 600040, Chennai, Tamil Nadu, 600040.
Pregio Pharma Private Limited was incorporated on 30 March 2011.
The current directors of Pregio Pharma Private Limited are
The primary industry of Pregio Pharma Private Limited is Manufacturing.
Pregio Pharma Private Limited is unlisted.
The authorized capital of Pregio Pharma Private Limited is ₹13.00 Cr, and the paid-up capital is ₹12.32 Cr.
The compliance status of Pregio Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX